Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Article History
Received: 14 September 2021
Accepted: 21 October 2021
First Online: 29 October 2021
Declarations
:
: TB has received lecture fees from Drägerwerk AG & Co. KGaA, Sedana Medical and Löwenstein Medical. DS has received lecture fees from Aerogen Ltd. IF has received funding from the European Commission (Projects CRADL, under Grant 668259, and WELMO, under Grant 825572) and speaking and congress fees from Drägerwerk AG & Co. KGaA.